Compare
NAVs as of 20 Aug 2026
HDFC Charity Fund for Cancer Cure - Regular Plan - 50% IDCW DonationRegular · IDCWKotak FMP Series 304 - Regular Plan - Payout ofRegular · IDCWSBI Fixed Maturity Plan (FMP) - Series 1 (3668 Days)Regular · IDCWHDFC FMP 2638D February 2023Regular · IDCW4 of 4 funds
Comparing the maximum of 4. Replace which fund?
Growth of ₹100 (rebased over the selected window)
Common period 14 Aug 2023 – 20 Aug 2026, limited by HDFC Charity Fund for Cancer Cure - Regular Plan - 50% IDCW Donation. Every series is rebased to ₹100 at the start of this window.
View as table
| Date | HDFC Charity Fund for Cancer Cure - Regular Plan - 50% IDCW Donation | Kotak FMP Series 304 - Regular Plan - Payout of | SBI Fixed Maturity Plan (FMP) - Series 1 (3668 Days) | HDFC FMP 2638D February 2023 |
|---|---|---|---|---|
| 14 Aug 2023 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 14 Nov 2023 | ₹101.51 | ₹100.91 | ₹101.13 | ₹101.10 |
| 14 Feb 2024 | ₹102.10 | ₹104.36 | ₹103.83 | ₹103.90 |
| 16 May 2024 | ₹104.15 | ₹106.52 | ₹105.84 | ₹105.95 |
| 15 Aug 2024 | ₹102.41 | ₹109.84 | ₹108.71 | ₹109.10 |
| 15 Nov 2024 | ₹104.43 | ₹111.71 | ₹110.87 | ₹111.05 |
| 15 Feb 2025 | ₹102.49 | ₹114.34 | ₹112.97 | ₹113.31 |
| 18 May 2025 | ₹105.04 | ₹119.98 | ₹117.44 | ₹118.47 |
| 18 Aug 2025 | ₹103.03 | ₹119.28 | ₹118.45 | ₹118.46 |
| 18 Nov 2025 | ₹104.70 | ₹121.81 | ₹120.40 | ₹120.82 |
| 17 Feb 2026 | ₹102.37 | ₹122.85 | ₹122.08 | ₹122.31 |
| 20 May 2026 | ₹103.78 | ₹122.55 | ₹122.32 | ₹122.05 |
| 20 Aug 2026 | ₹101.60 | ₹126.68 | ₹125.34 | ₹125.36 |
| Metric | HDFC · Regular · IDCW NAV ₹10.17 Moderate risk ★★☆☆☆ | Kotak Mahindra · Regular · IDCW NAV ₹13.31 Moderate risk ★★★★★ | SBI · Regular · IDCW NAV ₹17.54 Moderate risk ★★★☆☆ | HDFC · Regular · IDCW NAV ₹13.14 Moderate risk ★★★☆☆ | Category median Income · 39 funds |
|---|---|---|---|---|---|
| -1.35% | +6.07%Best in row | +5.83% | +5.82% | +5.82% | |
| +0.50% | +8.20%Best in row | +7.82% | +7.80% | +7.30% | |
| — | — | +6.77% | — | +6.51% | |
| +0.53% | +8.32%Best in row | +7.96% | +8.14% | +6.25% | |
| -0.59% | +7.65%Best in row | +7.35% | +7.25% | — | |
| +0.50% | +8.12%Best in row | +6.78% | +7.66% | +7.03% | |
| — | — | +6.91% | — | +6.31% | |
| Risk | |||||
| 4.93% | 2.74% | 1.22%Best in row | 2.10% | 0.70% | |
| -1.22 | 0.62 | 1.08Best in row | 0.62 | 0.90 | |
| -1.22 | 0.91 | 1.51Best in row | 0.90 | 1.31 | |
| -5.02% | -2.11% | -4.58% | -1.79%Best in row | -3.56% | |
| — | — | 0.20%Best in row | 0.38% | 0.27% | |
| ₹66.98Cr | ₹1.04L | ₹51.26Cr | ₹166.64Cr | ₹101.78Cr | |
| 14 Aug 2023 | 03 Jan 2023 | 04 Apr 2019 | 23 Feb 2023 | — | |
16 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Benchmark
- —
- Alpha
- —
- Beta
- —
- Upside capture
- —
- Downside capture
- —
- Exit load
- —
- Lock-in
- —
- Min SIP
- —
- Min lumpsum
- —
- Portfolio turnover
- —
- Manager
- —
- Holdings
- —
- Top 10 weight
- —
- Cash & equivalents
- —
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.